197 related articles for article (PubMed ID: 21176152)
1. Overexpression of proto-oncogene FBI-1 activates membrane type 1-matrix metalloproteinase in association with adverse outcome in ovarian cancers.
Jiang L; Siu MK; Wong OG; Tam KF; Lam EW; Ngan HY; Le XF; Wong ES; Chan HY; Cheung AN
Mol Cancer; 2010 Dec; 9():318. PubMed ID: 21176152
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia promotes HO-8910PM ovarian cancer cell invasion via Snail-mediated MT1-MMP upregulation.
Sun L; Lin P; Qin Z; Liu Y; Deng LL; Lu C
Exp Biol Med (Maywood); 2015 Nov; 240(11):1434-45. PubMed ID: 25681470
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.
Zhu M; Li M; Wang T; Linghu E; Wu B
Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460
[TBL] [Abstract][Full Text] [Related]
4. MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells.
Sodek KL; Ringuette MJ; Brown TJ
Br J Cancer; 2007 Aug; 97(3):358-67. PubMed ID: 17609667
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination.
Moss NM; Barbolina MV; Liu Y; Sun L; Munshi HG; Stack MS
Cancer Res; 2009 Sep; 69(17):7121-9. PubMed ID: 19706774
[TBL] [Abstract][Full Text] [Related]
7. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
8. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Cowden Dahl KD; Zeineldin R; Hudson LG
Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
[TBL] [Abstract][Full Text] [Related]
9. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen.
Moss NM; Liu Y; Johnson JJ; Debiase P; Jones J; Hudson LG; Munshi HG; Stack MS
Mol Cancer Res; 2009 Jun; 7(6):809-20. PubMed ID: 19509114
[TBL] [Abstract][Full Text] [Related]
11. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts.
Afzal S; Lalani EN; Poulsom R; Stubbs A; Rowlinson G; Sato H; Seiki M; Stamp GW
Hum Pathol; 1998 Feb; 29(2):155-65. PubMed ID: 9490275
[TBL] [Abstract][Full Text] [Related]
12. Expression of various matrix proteases and Ets family transcriptional factors in ovarian cancer cell lines: correlation to invasive potential.
Nishikawa A; Iwasaki M; Akutagawa N; Manase K; Yamashita S; Endo T; Kudo R
Gynecol Oncol; 2000 Nov; 79(2):256-63. PubMed ID: 11063654
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of MT1-MMP expression suppresses tumor cell invasion in metastatic human SW626 ovarian cancer cells.
Wu M; Xu G; Xi L; Wei J; Song A; Han Z; Zhou J; Wang S; Zhu T; Zhang A; Lu Y; Ma D
Oncol Rep; 2006 Feb; 15(2):501-5. PubMed ID: 16391876
[TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
D'Alessio S; Ferrari G; Cinnante K; Scheerer W; Galloway AC; Roses DF; Rozanov DV; Remacle AG; Oh ES; Shiryaev SA; Strongin AY; Pintucci G; Mignatti P
J Biol Chem; 2008 Jan; 283(1):87-99. PubMed ID: 17991754
[TBL] [Abstract][Full Text] [Related]
15. Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.
Yang J; Kasberg WC; Celo A; Liang Z; Quispe K; Stack MS
J Biol Chem; 2017 Aug; 292(32):13111-13121. PubMed ID: 28655772
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer.
Kamat AA; Fletcher M; Gruman LM; Mueller P; Lopez A; Landen CN; Han L; Gershenson DM; Sood AK
Clin Cancer Res; 2006 Mar; 12(6):1707-14. PubMed ID: 16551853
[TBL] [Abstract][Full Text] [Related]
17. Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion.
Dong Z; Xu X; Du L; Yang Y; Cheng H; Zhang X; Li Z; Wang L; Li J; Liu H; Qu X; Wang C
Carcinogenesis; 2013 May; 34(5):974-83. PubMed ID: 23354307
[TBL] [Abstract][Full Text] [Related]
18. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium.
Bruney L; Conley KC; Moss NM; Liu Y; Stack MS
Biol Chem; 2014 Oct; 395(10):1221-31. PubMed ID: 25205731
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
[TBL] [Abstract][Full Text] [Related]
20. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
